Public procurement notice: Contract Notice
Published: 2017-05-06
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Region: UNITED KINGDOM
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 11610898 GBP
Submission deadline: 2017-06-08
Award criteria: The most economic tender

Technical requirements: This framework agreement is for the supply of Methotrexate Pre Filled Syringes (PFS) and Pens to NHS Scotland.
The Goods have been split into three (3) categories, each of which are identified as a ‘Lot’. Full details of each Lot are contained in section II.2 of this notice.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT.
Option to extend by a further two (2) periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT.
Option to extend by a further two (2) periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of three (3) Framework Participants will be awarded. Full details can be found within the ITT.
Option to extend by a further two (2) periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 11610898